Literature DB >> 35707161

Modified Benzofuran-carboxamide Compounds as Glucosylceramide Synthase Inhibitors for Treating Diseases.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2022        PMID： 35707161      PMCID： PMC9190284          DOI： 10.1021/acsmedchemlett.2c00182

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  6 in total

Review 1.  Glycosphingolipid metabolism and polycystic kidney disease.

Authors:  Thomas A Natoli; Vijay Modur; Oxana Ibraghimov-Beskrovnaya
Journal:  Cell Signal       Date:  2020-01-10       Impact factor: 4.315

Review 2.  Ceramide glycosylation and related enzymes in cancer signaling and therapy.

Authors:  Zibo Li; Lin Zhang; Dan Liu; Caiyan Wang
Journal:  Biomed Pharmacother       Date:  2021-04-20       Impact factor: 6.529

Review 3.  Drugs repurposed: An advanced step towards the treatment of breast cancer and associated challenges.

Authors:  Jonaid Ahmad Malik; Sakeel Ahmed; Bisma Jan; Onur Bender; Turki Al Hagbani; Aali Alqarni; Sirajudheen Anwar
Journal:  Biomed Pharmacother       Date:  2021-12-01       Impact factor: 6.529

Review 4.  Therapeutic advances in Fabry disease: The future awaits.

Authors:  Sam Kant; Mohamed G Atta
Journal:  Biomed Pharmacother       Date:  2020-09-23       Impact factor: 6.529

Review 5.  Sphingolipids in embryonic development, cell cycle regulation, and stemness - Implications for polyploidy in tumors.

Authors:  Christina Voelkel-Johnson
Journal:  Semin Cancer Biol       Date:  2021-01-08       Impact factor: 17.012

Review 6.  Role of hypothalamic de novo ceramides synthesis in obesity and associated metabolic disorders.

Authors:  Christophe Magnan; Hervé Le Stunff
Journal:  Mol Metab       Date:  2021-07-15       Impact factor: 7.422
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.